Overview

A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the effect of repeated doses of intravenous BV100 on the pharma-cokinetics of midazolam and 1-hydroxymidazolam.
Phase:
Phase 1
Details
Lead Sponsor:
BioVersys AG
Collaborator:
CRU Hungary Kft
Treatments:
Midazolam